Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Patients With Previously Treated Multiple Myeloma: Three-year Follow-up of CASTOR
Titel:
Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Patients With Previously Treated Multiple Myeloma: Three-year Follow-up of CASTOR
Auteur:
Mateos, Maria-Victoria Sonneveld, Pieter Hungria, Vania Nooka, Ajay K. Estell, Jane A. Barreto, Wolney Corradini, Paolo Min, Chang-Ki Medvedova, Eva Weisel, Katja Chiu, Christopher Schecter, Jordan M. Amin, Himal Qin, Xiang Ukropec, Jon Kobos, Rachel Spencer, Andrew